Summary
85 / 100 · Bulios Score
What speaks for it
- It earns 24 EUR a year on every 100 EUR of invested capital.
- Out of every 100 EUR of revenue, 15 EUR is left as net profit.
- It holds more cash than debt: 10.2M € against 9.90M €.
- Revenue grew by 15% a year over the last 3 years.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.8 EUR for 1 EUR of yearly profit. Over the last five years it was 12.9 EUR on average.
Valuation in detailIs it growing?
Yes, fastRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 20% a year over 5 years. Over the last 3 years it grew by 15% a year. Earnings per share grew by 13% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 80 EUR
- Sales and administration 80 EUR
- Taxes and other 5.8 EUR
- Net profit 15 EUR
Net profit, industry median (Medical - Care Facilities) 6.8 EUR
Out of every 100 EUR of revenue, 15 EUR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.88%
- Paid out of profit
- 54%
You receive 1.57 € per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail